Deep learning-based classification of mesothelioma improves prediction of patient outcome
Top Cited Papers
- 7 October 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 25 (10), 1519-1525
- https://doi.org/10.1038/s41591-019-0583-3
Abstract
Malignant mesothelioma (MM) is an aggressive cancer primarily diagnosed on the basis of histological criteria1. The 2015 World Health Organization classification subdivides mesothelioma tumors into three histological types: epithelioid, biphasic and sarcomatoid MM. MM is a highly complex and heterogeneous disease, rendering its diagnosis and histological typing difficult and leading to suboptimal patient care and decisions regarding treatment modalities2. Here we have developed a new approach—based on deep convolutional neural networks—called MesoNet to accurately predict the overall survival of mesothelioma patients from whole-slide digitized images, without any pathologist-provided locally annotated regions. We validated MesoNet on both an internal validation cohort from the French MESOBANK and an independent cohort from The Cancer Genome Atlas (TCGA). We also demonstrated that the model was more accurate in predicting patient survival than using current pathology practices. Furthermore, unlike classical black-box deep learning methods, MesoNet identified regions contributing to patient outcome prediction. Strikingly, we found that these regions are mainly located in the stroma and are histological features associated with inflammation, cellular diversity and vacuolization. These findings suggest that deep learning models can identify new features predictive of patient survival and potentially lead to new biomarker discoveries.Keywords
This publication has 35 references indexed in Scilit:
- Prognostic Significance of Ki67 Expression in Malignant Peritoneal MesotheliomaAmerican Journal of Clinical Oncology, 2015
- Deep learningNature, 2015
- The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markersOncoImmunology, 2015
- Mésothéliome : les dispositifs en place en France « le réseau mésothéliome » 1998–2013Annales de Pathologie, 2014
- Influence of tumour micro-environment heterogeneity on therapeutic responseNature, 2013
- Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with SurvivalScience Translational Medicine, 2011
- Pleomorphic Epithelioid Diffuse Malignant Pleural Mesothelioma: A Clinicopathological Review and Conceptual Proposal to Reclassify as Biphasic or Sarcomatoid MesotheliomaJournal of Thoracic Oncology, 2011
- On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival dataStatistics in Medicine, 2011
- Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomasVirchows Archiv, 2008
- Advances in Malignant MesotheliomaThe New England Journal of Medicine, 2005